Walter Bushnell Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-06-2024
- Paid Up Capital ₹ 0.10 M
as on 02-06-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -21.06%
(FY 2022)
- Profit -200.24%
(FY 2022)
- Ebitda -98.26%
(FY 2022)
- Net Worth -1.44%
(FY 2022)
- Total Assets -1.92%
(FY 2022)
About Walter Bushnell Biosciences
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Sabherwal, Prabhudas Gohil, and Brij Nandan serve as directors at the Company.
- CIN/LLPIN
U24232PB2007PTC053382
- Company No.
165425
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Walter Bushnell Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Sabherwal  | Director | 01-Apr-2008 | Current |
| Prabhudas Gohil | Director | 29-May-2019 | Current |
| Brij Nandan | Director | 09-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Walter Bushnell Biosciences.
Walter Bushnell Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 21.06% decrease. The company also saw a substantial fall in profitability, with a 200.24% decrease in profit. The company's net worth dipped by a decrease of 1.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Walter Bushnell Biosciences?
In 2019, Walter Bushnell Biosciences had a promoter holding of 99.59% and a public holding of 0.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Walter Bushnell Lifescience Private LimitedActive 2 years 9 monthsPrabhudas Gohil is a mutual person
Walter Bushnell Medisafe Private LimitedActive 16 years 8 monthsPrakash Sabherwal and Prabhudas Gohil are mutual person
Walter Bushnell Healthsciences Private LimitedActive 17 years 5 monthsPrakash Sabherwal, Prabhudas Gohil and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Walter Bushnell Biosciences?
Walter Bushnell Biosciences has a workforce of 74 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Walter Bushnell Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Walter Bushnell Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
